Travel Vaccines Checklist: Which Ones by Destination and When to Book Them

The itinerary was perfect, the flights were paid for, and the vaccine appointment was booked for the Tuesday before a Saturday departure to Tanzania. That is the kind of scheduling that makes travel clinicians wince. Not because anything terrible happens at day four, but because a yellow fever certificate does not become valid until ten days after the injection, and border officers know it.

Searches for travel vaccines climb every booking season, and as of January 2026 they are climbing faster than usual. Three things are feeding the surge: measles alerts tied to international travel, changes in the chikungunya vaccine landscape in the United States, and a viral social post insisting that eleven vaccines are now required to fly abroad. That last claim is false, and untangling it turns out to be the best way to understand how travel vaccination actually works.

So here is the calm version: what is required, what is recommended, what depends on your itinerary, and how far ahead the calendar needs to bend.

What travel vaccines do I actually need?

Most people picture travel vaccines as a special menu of exotic injections. In practice, the list a travel clinician builds for you has three layers, and the first layer is not exotic at all.

The foundation is your routine schedule: measles-mumps-rubella (MMR), tetanus-diphtheria-pertussis (Tdap), seasonal influenza, COVID-19, and for many adults hepatitis B, varicella and shingles. The CDC’s travelers’ health guidance opens with exactly this point, because the infections most often brought home by travelers are not tropical curiosities but measles and influenza, diseases that circulate in airports and cruise terminals as easily as in villages.

The second layer is recommended vaccines, chosen by destination, season, length of stay and activities. Hepatitis A and typhoid appear on nearly every list for low- and middle-income destinations because both spread through food and water. Rabies enters the picture for rural travel, long stays, cycling or work with animals. Japanese encephalitis matters for extended rural stays in parts of Asia during transmission season. Cholera, tick-borne encephalitis and meningococcal vaccines are added for specific regions and situations.

The third and thinnest layer is required vaccines, meaning those a country can legally demand at its border under the International Health Regulations, the WHO treaty that governs cross-border disease control. That layer is covered in the next section, and it is much smaller than the internet suggests.

A helpful way to think about it: the routine layer protects the people you come home to, the recommended layer protects you, and the required layer protects the country you are entering. A good pre-travel visit works through all three, usually in that order. If your routine vaccines are years out of date, the clinician will often prioritize those over anything with a tropical name.

Are any vaccines actually required to travel?

Legally required travel vaccines are rarer than most travelers assume. The WHO’s International Health Regulations allow countries to require proof of only a handful of vaccinations, and in practice three appear on entry rules.

Yellow fever leads the list. Dozens of countries in sub-Saharan Africa and tropical South America either require an International Certificate of Vaccination or Prophylaxis from every arriving traveler or require it from travelers arriving from another yellow fever country. Yellow fever is a mosquito-borne viral infection that can cause liver failure and bleeding, and the vaccine is the only one whose certificate is standardized worldwide. Since 2016 the WHO has treated that certificate as valid for life; the old ten-year renewal rule no longer applies, though a few border posts have been slow to update their paperwork.

Polio comes second. Countries where wild or vaccine-derived poliovirus is still circulating may require departing long-stay visitors and residents to show proof of a recent polio vaccination, and the WHO periodically issues temporary recommendations naming those countries. The CDC destination pages flag when this applies.

Meningococcal vaccine rounds out the trio. Saudi Arabia requires proof of vaccination against meningococcal disease, a bacterial infection of the brain lining and bloodstream, for anyone arriving for Hajj or Umrah, because pilgrim gatherings have historically seeded outbreaks.

That is the full legal list. Nothing about hepatitis A, typhoid, rabies or influenza is enforced at a border, however strongly it may be recommended. COVID-19 entry requirements, which were widespread in 2021 and 2022, have been dropped by essentially every country as of early 2026.

Because requirements shift with outbreaks, the reliable move is to check the CDC destination page or the NHS travel vaccination guidance for each country on your itinerary, including any transit stops longer than twelve hours, a few weeks before you fly and again a few days before departure.

What changed recently

Travel vaccination advice moves slowly, but the past two years have brought several updates worth knowing about as of January 2026.

Measles is the biggest shift. Through 2024 and 2025 the United States recorded its largest measles case counts in decades, most traced to unvaccinated travelers, and the CDC broadened its travel guidance: its Plan for Travel page now advises that all international travelers, whatever the destination, be fully protected against measles before departure, and that anyone unsure of their status talk to a clinician at least six weeks out. The NHS has made a parallel push after measles outbreaks in England, tying it to travel across Europe. The evidence behind this is strong; MMR was studied in randomized trials and decades of surveillance confirm roughly 97 percent protection after a completed course.

Whooping cough is the second story. CDC surveillance recorded more than 35,000 reported pertussis cases in 2024, the highest total in over a decade, with 2025 running at similar or higher levels. Travel clinicians increasingly treat the adult Tdap check as part of the pre-travel visit rather than an afterthought.

Chikungunya, a mosquito-borne virus causing fever and lasting joint pain, has had a turbulent year. One licensed vaccine, Ixchiq, had its US license suspended in 2025 after reports of serious adverse events in older adults; a second vaccine, Vimkunya, remains approved. Anyone offered chikungunya vaccination should expect a careful eligibility conversation, and the decision belongs entirely to the treating clinician.

Yellow fever rules have also been quietly tidied. The WHO’s lifetime-certificate policy from 2016 is now near-universally honored, and the CDC Yellow Book, its biennial travel medicine reference, lists which countries still ask for proof.

None of these changes adds a new requirement for the average tourist. They mostly raise the bar on the routine layer, which is exactly where the evidence says risk lives.

Travel vaccines by destination: a summary table

Every itinerary is different, and a beach resort in the same country as a jungle trek carries different risks. Even so, regional patterns are consistent enough that a summary table is genuinely useful as a starting point. It is a prompt for your travel health visit, not a substitute for one, and it assumes your routine vaccines are up to date.

Region	Commonly recommended	Sometimes recommended	May be required at border
Sub-Saharan Africa	Hepatitis A, typhoid	Rabies, meningococcal (dry-season belt), cholera, hepatitis B	Yellow fever (many countries); polio (select countries)
South & Southeast Asia	Hepatitis A, typhoid	Japanese encephalitis (rural, seasonal), rabies, hepatitis B, cholera	Polio proof for long stays from a few countries
Central & South America	Hepatitis A, typhoid	Rabies, hepatitis B	Yellow fever (Amazon basin and several other areas)
Middle East	Hepatitis A	Typhoid, hepatitis B, rabies	Meningococcal for Hajj/Umrah
Eastern Europe & Central Asia	Hepatitis A	Tick-borne encephalitis (forest travel), rabies, typhoid	None routinely
Western Europe, Australia, Japan, North America	Routine vaccines only	Tick-borne encephalitis (parts of Europe), Japanese encephalitis (rural Japan, rarely)	None
Caribbean & Pacific islands	Hepatitis A	Typhoid, hepatitis B	None routinely

Two patterns jump out. Hepatitis A shows up almost everywhere outside high-income countries, which is why many clinicians call it the default travel vaccine. And the required column is nearly empty, because border enforcement is limited to the diseases discussed earlier.

The table also hides the biggest variable of all: you. A two-week stay in air-conditioned hotels and a six-month volunteer placement in a rural clinic sit in the same row but warrant very different plans. Duration, accommodation, whether you will handle animals, whether you are pregnant or immunocompromised, and what season you travel in all move items between columns. That is the conversation a travel clinician is for.

Routine vaccines first: the shots that matter before any tropical ones

The most common serious vaccine-preventable infection in returning travelers is not typhoid or yellow fever. It is measles. That single fact should reorganize how you think about pre-travel appointments.

Measles is extraordinarily contagious; the CDC estimates that about nine in ten unprotected people exposed to the virus will catch it, and the virus lingers in the air of a room for up to two hours after an infected person leaves. Airports, long-haul flights and crowded attractions are ideal settings. Adults born before 1957 in the United States are generally presumed immune through childhood exposure; nearly everyone else needs documented MMR vaccination or a blood test showing immunity. The CDC’s travel guidance now asks every international traveler, regardless of destination, to confirm measles protection before departure.

Tetanus and diphtheria come next. Tetanus lives in soil worldwide, so a scraped knee on a hiking trail in Portugal carries the same tetanus risk as one in Peru. Diphtheria, a bacterial throat infection that can block the airway, has made a modest comeback in several regions where childhood vaccination slipped. The adult combination vaccine, Tdap, also covers whooping cough, and clinicians check when your last booster was; a periodic adult booster is standard CDC guidance, with the exact timing decided at your visit.

Influenza is the third pillar, and the one travelers most often skip. Flu circulates year-round in the tropics and follows the opposite calendar in the Southern Hemisphere, so a July trip to Argentina lands squarely in flu season. The annual vaccine is supported by randomized trials and large observational studies, with effectiveness that varies by season, typically in the 40 to 60 percent range when the vaccine and circulating strains match well.

COVID-19 vaccination rounds out the routine layer. Entry mandates are gone, but crowded transit and long flights have not changed, and staying current under CDC or NHS eligibility guidance remains the recommendation.

Get these sorted first. The tropical vaccines are the garnish; the routine schedule is the meal.

Does the whooping cough vaccine for adults belong on a travel list?

Whooping cough, or pertussis, is a bacterial infection of the airways that causes violent coughing fits lasting weeks; the name comes from the gasping inhale that follows each spasm. Most adults associate it with infants, and with good reason: babies too young to be fully vaccinated account for nearly all pertussis deaths. That is precisely why the adult whooping cough vaccine has crept onto travel checklists.

Protection from childhood pertussis vaccination fades over years, so adults are the reservoir that carries the bacteria to infants. CDC surveillance in 2024 counted more than 35,000 reported cases in the United States, the highest annual total since 2012, and 2025 continued at a high level. Similar surges appeared in the UK and much of Europe. Travelers who spend time in crowded settings, then return to households with newborns or pregnant relatives, are an obvious link in that chain.

The vaccine used in adults is Tdap, which combines tetanus, diphtheria and pertussis components in one injection. CDC guidance recommends Tdap for every adult who has never received it, a booster during each pregnancy so that antibodies cross to the baby before birth, and periodic tetanus-diphtheria boosters thereafter, with timing set by your clinician. The NHS offers pertussis vaccination in pregnancy on the same rationale.

How strong is the evidence? The pregnancy recommendation rests on large observational studies from England and the United States showing roughly 90 percent protection against infant pertussis in the first weeks of life, an effect size unusually large for observational data. For adult boosters outside pregnancy, evidence comes from immunogenicity trials and surveillance rather than outcome trials, so it is graded as moderate. Protection after adult Tdap is real but wanes, likely within several years.

None of this makes whooping cough vaccine adults-specific travel medicine in the way yellow fever is. It simply means the pre-travel visit is a convenient moment to close a common gap. Whether you need Tdap now, and how it fits with any other vaccines being given that day, is a decision for the clinician holding your record.

Hepatitis A, typhoid and hepatitis B: the food, water and blood trio

If the routine vaccines protect you from other people, this trio protects you from lunch, from the tap, and from the unexpected clinic visit.

Hepatitis A is a viral liver infection spread through contaminated food and water, and it is the vaccine most consistently recommended for travel outside high-income countries. Infection causes weeks of fatigue, nausea and jaundice and occasionally severe liver injury; in a traveler it can wipe out a month of work. The vaccine is inactivated, meaning it contains killed virus, and protection begins within about two weeks of vaccination, a fact the CDC highlights because it means even late bookers benefit. Completing the course extends protection for decades. Randomized trials in the 1990s showed efficacy above 90 percent, and surveillance since has confirmed durable immunity, so the evidence grade is high.

Typhoid fever is a bacterial infection, caused by Salmonella Typhi, that spreads the same way and produces sustained high fever, headache and abdominal pain. It is recommended for South Asia in particular, where drug-resistant strains have emerged, and for much of Africa and Latin America, especially for travelers visiting friends and relatives or eating outside tourist restaurants. Two types exist: an injected vaccine and an oral live vaccine, and which suits you depends on age, health and timing. Efficacy is moderate, in the range of 50 to 80 percent in trials, which is why clinicians pair the vaccine with food and water precautions rather than treating it as a shield.

Hepatitis B spreads through blood and body fluids, so the travel risk comes from medical or dental care abroad, tattoos, piercings, sexual contact, or long stays where an accident could land you in a hospital. Many adults born after the early 1990s were vaccinated in childhood; others were not. The CDC now recommends hepatitis B vaccination for all adults through age 59 regardless of travel, and for older adults with risk factors or by choice.

Together these three form the core of most itineraries. Your clinician will decide which apply, and whether your timeline allows a full course before you leave.

Yellow fever vaccine requirements: certificates, eligibility and the ten-day rule

Yellow fever is the one travel vaccine where the paperwork matters as much as the immunology, so it earns its own section.

The disease is a mosquito-borne viral infection found in tropical Africa and South America. Most infections cause fever and aches; roughly 15 percent progress to a severe phase with jaundice, bleeding and organ failure, and among those, the WHO estimates that around half die. There is no antiviral treatment, which is why prevention carries such weight.

The vaccine is live-attenuated, meaning it contains a weakened virus that trains the immune system without causing disease. Protection is excellent; studies of antibody levels show that a completed vaccination protects the large majority of recipients for life, which is the evidence base behind the WHO’s 2016 decision to make certificates permanently valid. The certificate itself is a yellow booklet or page called the International Certificate of Vaccination or Prophylaxis, and it must be signed and stamped at an authorized yellow fever vaccination center, since ordinary clinics are not permitted to issue it.

Then comes the ten-day rule. The certificate becomes valid ten days after vaccination, because that is roughly how long the immune response takes. Arrive at a requiring border on day seven and you may be refused entry, quarantined or vaccinated on the spot. Book accordingly.

Eligibility is where the neutral, careful conversation happens. CDC and WHO guidance generally supports vaccination from nine months of age for travel to risk areas. The vaccine is not given to infants under six months, to people with severely weakened immune systems, or to those with a thymus disorder, because a live vaccine can cause serious illness in those groups. Adults over 60 receiving it for the first time face a small but higher risk of rare serious reactions, so clinicians weigh destination risk against age. Pregnant and breastfeeding travelers, and people with milder immune conditions, fall into a precaution category requiring individual assessment.

When the vaccine is inadvisable but a country requires it, an authorized clinician can issue a medical waiver letter. Some countries accept these and some do not, so the decision is made with the destination’s rules in hand. It is your clinician’s call, informed by the CDC Yellow Book country tables.

Rabies, Japanese encephalitis and the diseases with no travel vaccine

Beyond the core list sit the situational vaccines, chosen for specific trips, and beside them a group of important diseases where vaccination is not the answer at all.

Rabies is a viral infection of the nervous system transmitted through the saliva of infected animals, most often dogs in Asia and Africa, and once symptoms appear it is almost universally fatal. Pre-travel rabies vaccination does not remove the need for urgent care after a bite; it changes what that care involves, simplifying and shortening the post-exposure treatment and removing the need for rabies immunoglobulin, a blood product that is scarce in many countries. The CDC recommends it for travelers spending long periods in risk areas, for those in remote places far from reliable care, for cyclists, cavers and anyone working with animals, and increasingly for children, who are bitten more often and report it less. Evidence for its immunogenicity is strong; the practical benefit is documented in observational cohorts of exposed travelers.

Japanese encephalitis is a mosquito-borne viral brain infection found across rural Asia and the western Pacific. Risk to the average short-stay tourist is very low, on the order of one case per million visitors, but rises sharply for a month or more in rural areas during transmission season. The inactivated vaccine is supported by trials showing high antibody response, and the CDC frames the decision around itinerary rather than country.

Tick-borne encephalitis, cholera and meningococcal vaccines fill similar niches, each tied to forests, outbreak zones or mass gatherings.

Then the gap. Malaria, the parasitic infection that kills more travelers than any of the above, has no vaccine available for travelers; the two malaria vaccines the WHO recommends are for young children living in high-transmission African regions. Travelers rely on prescribed antimalarial tablets, bed nets and repellent, and the choice of tablet is made by a clinician based on destination and health history. Dengue, the mosquito-borne cause of fever and severe body aches, has vaccines licensed in some countries with eligibility restrictions, but for most travelers prevention still means repellent, long sleeves and screened rooms. Chikungunya vaccination, as noted earlier, is in flux in the United States. For all four, the mosquito is the real target.

When to book travel vaccines: a realistic timeline

The CDC’s headline advice is to see a travel health provider at least four to six weeks before departure, and the NHS gives the same window. The number is not arbitrary. It reflects three biological and logistical clocks running at once.

The first clock is immune response. Most inactivated vaccines take about two weeks to build protective antibody levels; yellow fever certificates become valid at ten days. Anything given inside that window may still help, but you leave with partial protection.

The second is multi-visit courses. Several travel vaccines, hepatitis B, Japanese encephalitis, rabies and tick-borne encephalitis among them, are given as a series spread over weeks, and while accelerated schedules exist for some, they are a clinician’s decision and not always possible. Six weeks gives room for the standard versions.

The third clock is supply and access. Yellow fever vaccine can only be given at authorized centers, some of which book weeks out in peak season. Rabies vaccine has faced intermittent shortages. And your own records may take time to locate; many travelers discover they cannot find their childhood immunization card and need a blood test or a repeat vaccination.

A practical calendar looks like this. Eight to twelve weeks out: check the CDC or NHS destination pages, dig out your vaccination record, and book the appointment. Six weeks out: the visit itself, where routine gaps and the first doses of any series are handled. Two to four weeks out: return for any remaining injections in a series. Ten days out at the absolute latest: yellow fever, if required. Departure week: pack the certificate with your passport, not in checked luggage.

Travel nurses and physicians also see plenty of people two days before a flight. The honest message for them is that it is still worth going. Hepatitis A protection starts fast, measles vaccination remains worthwhile, and antimalarial prescriptions and travel advice do not require lead time. Late is better than never; early is simply better.

What the evidence actually says about travel vaccines

Not all travel vaccine recommendations rest on the same kind of evidence, and an honest checklist should say so. Here the grades run from randomized trials, the strongest form, through observational data to expert consensus.

The routine vaccines carry the heaviest evidence. MMR, tetanus-diphtheria, pertussis, hepatitis A and hepatitis B were all tested in randomized controlled trials before licensing, and decades of population surveillance have confirmed their effectiveness and safety profile in hundreds of millions of recipients. This is high-grade evidence by any standard.

Yellow fever sits in an unusual spot. The vaccine dates to the 1930s and was never subjected to a modern placebo-controlled efficacy trial, because withholding it in an epidemic zone would be unethical. Its evidence comes from outbreak investigations, antibody studies and the near-disappearance of the disease among vaccinated populations, which regulators and the WHO treat as compelling. Grade: high, by convergent observational evidence.

Typhoid vaccines have randomized trial data showing moderate efficacy, roughly 50 to 80 percent, and newer conjugate typhoid vaccines have shown higher protection in large trials in Nepal, Malawi and Bangladesh, though those products are not yet widely used for travelers in the United States. Grade: moderate to high, depending on product.

Rabies and Japanese encephalitis vaccines were licensed largely on immunogenicity, meaning they reliably produce protective antibody levels, with clinical benefit inferred from surveillance and cohort data rather than outcome trials. Grade: moderate, with strong biological plausibility.

Recommendations about who needs which vaccine, the itinerary-based judgment calls, are mostly expert consensus built on case reports and surveillance of returning travelers. That is the weakest tier, and it is why two competent clinicians may reasonably differ on whether a ten-day trip warrants a rabies course.

What the evidence does not support: the idea that vaccines are the main protection against travel illness. The most common problems travelers face, diarrhea, respiratory infections, injuries and mosquito bites, are managed by behavior, not injection. Vaccines close specific, serious gaps. They are essential and they are not sufficient.

Common myths about travel vaccines, corrected

The current wave of search interest is partly driven by claims that do not survive contact with the guidelines. A few deserve direct correction.

“Eleven vaccines are now required to travel.” No country requires eleven vaccines, and no international body has proposed such a rule. The number appears to come from a misreading of the CDC’s full list of travel-related vaccines, which is a menu of possibilities, not a mandate. Under the International Health Regulations only yellow fever, polio in specific circumstances and meningococcal vaccine for Hajj are enforced at borders.

“If it isn’t required, it isn’t important.” The opposite is closer to the truth. Requirements exist to protect the destination country from importation. Recommendations exist to protect you, and hepatitis A, which is never required, prevents far more traveler illness than yellow fever, which is.

“My yellow fever certificate expires after ten years.” It did until 2016, when the WHO amended the rules to lifetime validity. Certificates issued earlier are now considered valid indefinitely.

“Travel vaccines are dangerous to get all at once.” Giving several vaccines in one visit is standard practice supported by decades of immunology; the immune system handles many antigens simultaneously. The one genuine constraint involves live vaccines, which clinicians space appropriately, and that scheduling is their job.

“Natural immunity from travel is better than vaccination.” Acquiring hepatitis A, typhoid or measles to gain immunity means having the disease, with its hospitalizations and occasional deaths. No guideline body endorses this.

“Short trips don’t need vaccines.” Duration lowers some risks and not others. A single contaminated meal on day two causes hepatitis A just as effectively as one on day sixty.

“I had my childhood shots, so I’m covered.” Tetanus and pertussis protection wanes; adults born in certain years may have received only a partial measles schedule; and none of the destination-specific vaccines are part of any childhood program. Records, not memory, settle the question.

Travel vaccines in pregnancy, childhood, older age and with a weakened immune system

Guidelines describe the average traveler. Several groups need the itinerary judged differently, and in each case the treating clinician makes the final call.

Pregnancy changes the live-vaccine calculus. Inactivated vaccines such as hepatitis A, hepatitis B, influenza, Tdap and inactivated typhoid are generally considered appropriate when indicated, and Tdap is actively recommended during pregnancy under CDC and NHS guidance. Live vaccines, including MMR, the oral typhoid vaccine and yellow fever, are usually avoided; yellow fever becomes an individual risk-benefit discussion if travel to a high-risk area cannot be postponed. Malaria in pregnancy is especially dangerous, so destination choice itself may be the most important decision.

Children can receive most travel vaccines, with minimum ages that vary by product; yellow fever is generally given from nine months, and Japanese encephalitis and rabies vaccines have pediatric guidance. Infants too young for MMR are the group most vulnerable to measles on international trips, and the CDC provides specific early-vaccination advice for them that a pediatrician applies case by case.

Older adults face two shifts. Immune responses to some vaccines are modestly weaker with age, and first-time yellow fever vaccination after 60 carries a small increased risk of rare serious reactions, so clinicians weigh true exposure risk carefully. Age is also when routine gaps, shingles, pneumococcal and updated tetanus, get caught during travel visits.

People with weakened immune systems, whether from disease or from medicines such as chemotherapy, high-dose steroids or biologic drugs, generally cannot receive live vaccines and may respond less well to inactivated ones. Yellow fever is contraindicated in severe immunosuppression, and a medical waiver letter may be issued instead. Timing vaccines relative to treatment cycles is a specialist decision, ideally made jointly with the prescribing physician.

Travelers visiting friends and relatives in their country of origin deserve a mention. Studies consistently show this group has higher rates of typhoid, malaria and hepatitis A, partly because familiarity breeds fewer precautions. Growing up somewhere does not confer lasting immunity to its water.

When to see a doctor about travel vaccines, before and after your trip

Two appointments bracket a well-planned trip: one before departure to plan vaccination, and one after return if anything goes wrong. Knowing when each is urgent is part of the checklist.

Before travel, book a visit with a travel health clinician or your primary care provider at least four to six weeks ahead, sooner if your itinerary includes yellow fever countries, rural or long stays, pregnancy, young children, or any condition or medicine that affects your immune system. Bring your vaccination records, your full itinerary including transit stops, and a list of current medicines. Every vaccine decision, which ones, in what order, and whether any should be skipped or replaced with a waiver letter, belongs to that clinician.

After vaccination, mild soreness, fatigue or a low fever for a day or two is common and expected. Seek care promptly if you develop a rash that spreads quickly, swelling of the face or throat, difficulty breathing, a racing heart or faintness within minutes to hours, which can signal a severe allergic reaction, or a high fever, confusion, severe headache or unusual weakness in the days after a live vaccine such as yellow fever.

During and after travel, certain symptoms are red flags regardless of vaccination status. Fever during or within a month of returning from a malaria area is a medical emergency until malaria is excluded; tell the clinician where you traveled. Any animal bite, scratch or lick to broken skin in a rabies area needs immediate wound washing and urgent medical assessment, even if you were vaccinated beforehand. Persistent diarrhea beyond a few days, bloody stools, yellowing of the eyes or skin, a severe headache with stiff neck, or a rash with fever all warrant prompt evaluation.

Symptoms can surface weeks after a trip, so mention recent travel at any medical visit for up to a year. Vaccination narrows the list of possibilities a doctor must consider; it does not close it. That candor, before and after the trip, is what a good travel health plan looks like.

Frequently asked questions

What vaccines do I need to travel?

It depends on your destination, activities and current records, but the pattern is consistent: routine vaccines such as MMR, Tdap, flu and COVID-19 first, then destination-based ones such as hepatitis A and typhoid for most low- and middle-income countries, with rabies, Japanese encephalitis or yellow fever added for specific itineraries. Check the CDC or NHS destination page for each country, then confirm the list with a travel health clinician.

Are any vaccines actually required to travel?

Very few. Under the WHO International Health Regulations, countries may require proof of yellow fever vaccination, and many in Africa and South America do. Some countries with circulating poliovirus require polio proof from long-stay visitors, and Saudi Arabia requires meningococcal vaccination for Hajj and Umrah pilgrims. Everything else, including hepatitis A, typhoid and influenza, is recommended rather than enforced at borders.

What are the 11 vaccines now required for travel?

There is no such requirement. The claim circulating online appears to misread the CDC’s list of vaccines that may be relevant to travel as a mandate. No country demands eleven vaccines at its border, and the only enforceable ones remain yellow fever, polio in specific circumstances and meningococcal vaccine for Hajj. Recommendations for other vaccines are made individually based on destination and health.

How far in advance should I get travel vaccines?

The CDC and NHS both advise a travel health visit at least four to six weeks before departure. That window allows time for immune responses to develop, for multi-visit vaccine series such as hepatitis B or rabies, and for yellow fever certificates, which become valid ten days after vaccination. If you are leaving sooner, go anyway; hepatitis A protection starts quickly and advice on malaria prevention needs no lead time.

Do adults need the whooping cough vaccine before traveling?

Adults who have never received Tdap, and pregnant travelers in each pregnancy, are recommended to have it under CDC and NHS guidance regardless of travel. With reported US pertussis cases at their highest level in over a decade during 2024 and 2025, many travel clinicians check adult whooping cough vaccine status at the pre-travel visit, particularly for people who will return to households with infants. Your clinician decides timing.

Which countries require the yellow fever vaccine?

Many countries in sub-Saharan Africa and tropical South America require an International Certificate of Vaccination, either from all arrivals or from travelers coming from other yellow fever areas. The exact list changes, so check the CDC destination pages or the CDC Yellow Book country tables for each stop, including transit. The certificate must be issued at an authorized yellow fever vaccination center.

Is it safe to get several travel vaccines at once?

Yes, giving multiple vaccines in one visit is standard practice supported by decades of immunology and surveillance; the immune system handles many antigens at the same time. Clinicians do pay attention to spacing between certain live vaccines and to specific combinations, and they manage that scheduling for you. Expect mild arm soreness or tiredness for a day or two, which is common and not a sign of a problem.

Do I need travel vaccines for Europe?

For most of Western Europe, routine vaccines are all you need, and confirming MMR protection matters given recent measles outbreaks. Tick-borne encephalitis vaccine is sometimes recommended for hiking, camping or forestry in parts of Central and Eastern Europe during warmer months, and hepatitis A may be suggested for some Eastern European destinations. A travel clinician can match this to your specific itinerary.

Is there a travel vaccine for malaria or dengue?

Not for most travelers. The two malaria vaccines the WHO recommends are for young children living in high-transmission African regions, not for visitors, so travelers rely on prescribed antimalarial tablets plus repellent, nets and clothing. Dengue vaccines exist in some countries with eligibility restrictions, but for the typical traveler prevention still means avoiding mosquito bites. Discuss both with your clinician.

What if I lost my vaccination records?

Start with your primary care provider, previous pharmacies, your state or regional immunization registry, and school or employer health files. Where no record exists, a clinician may order blood tests to check immunity for diseases such as measles or hepatitis B, or may simply revaccinate, since repeating most vaccines is considered safe. Bring whatever you find to the travel visit; even partial records help.

References

• CDC: Measles: Plan for Travel
• NHS: Travel vaccinations
• WHO: International travel and health
• MedlinePlus: Traveler's Health

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.